1,2-distearoyllecithin has been researched along with Esophageal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akiyama, S; Dohmitsu, K; Itoh, K; Kataoka, M; Kawasaki, S; Kondoh, K; Takagi, H; Watanabe, T; Yamauchi, M | 1 |
1 other study(ies) available for 1,2-distearoyllecithin and Esophageal Neoplasms
Article | Year |
---|---|
[Hyper-thermo chemotherapy of esophageal cancer with thermosensitive liposome, TAC-1043].
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Carriers; Drug Screening Assays, Antitumor; Esophageal Neoplasms; Hot Temperature; Humans; Liposomes; Mammary Neoplasms, Experimental; Mice; Phosphatidylcholines; Tumor Cells, Cultured | 1991 |